Jun 02, 2022 / 05:30PM GMT
Lee Michael Hambright - Sanford C. Bernstein & Co., LLC., Research Division - Analyst
Well, thanks, everybody, for joining. I'm Lee Hambright, U.S. Medical Devices Analyst at Bernstein. We're really thrilled to have Mike Mussallem from Edwards today. Mike is going to start us off with a few opening remarks, and then we'll jump into Q&A.
Mike, thanks very much for being here.
Michael A. Mussallem - Edwards Lifesciences Corporation - Chairman & CEO
Okay. Yes. Thanks, Lee. Thanks all for your interest in Edwards. I just thought I'd start out here for those people that aren't so close with a quick overview of the company, include -- let's see here, there we go.
I'll be making some forward-looking statements that, of course, involve risks and there's lots -- all those risks are listed on our website and in the SEC, and we all see some non-GAAP financial measures to make ourselves a little easier to understand. And there's a reconciliation of all those that are also available on our website and on file with all of our financials.
Edwards Lifesciences Corp at Sanford C Bernstein Strategic Decisions Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers